These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 1824824)
1. Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate. Schwartz GK; Arkin H; Holland JF; Ohnuma T Cancer Res; 1991 Jan; 51(1):55-61. PubMed ID: 1824824 [TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate. Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416 [TBL] [Abstract][Full Text] [Related]
3. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate. Takemura Y; Ohnuma T Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841 [TBL] [Abstract][Full Text] [Related]
4. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells. Aftab DT; Yang JM; Hait WN Oncol Res; 1994; 6(2):59-70. PubMed ID: 7949466 [TBL] [Abstract][Full Text] [Related]
5. Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin. Ahmad S; Trepel JB; Ohno S; Suzuki K; Tsuruo T; Glazer RI Mol Pharmacol; 1992 Dec; 42(6):1004-9. PubMed ID: 1362242 [TBL] [Abstract][Full Text] [Related]
6. Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells. Lee SA; Karaszkiewicz JW; Anderson WB Cancer Res; 1992 Jul; 52(13):3750-9. PubMed ID: 1617646 [TBL] [Abstract][Full Text] [Related]
7. [Correlation of protein kinase C activity and its subcellular distrubution with multidrug resistance in KVB200 cells]. Sun AM; Yuan YW; Li CG; Chen J; Xiao MX; Zhao MF Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):121-3. PubMed ID: 12390803 [TBL] [Abstract][Full Text] [Related]
8. Protein kinase C in adriamycin action and resistance in mouse sarcoma 180 cells. Posada J; Vichi P; Tritton TR Cancer Res; 1989 Dec; 49(23):6634-9. PubMed ID: 2819714 [TBL] [Abstract][Full Text] [Related]
9. Involvement of the alpha isoenzyme of protein kinase C in the growth inhibition induced by phorbol esters in MH1C1 hepatoma cells. Perletti GP; Smeraldi C; Porro D; Piccinini F Biochem Biophys Res Commun; 1994 Dec; 205(3):1589-94. PubMed ID: 7811240 [TBL] [Abstract][Full Text] [Related]
10. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists. Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176 [TBL] [Abstract][Full Text] [Related]
11. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate. Diddens H; Niethammer D; Jackson RC Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514 [TBL] [Abstract][Full Text] [Related]
12. Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine. Komarov PG; Shtil AA; Holian O; Tee L; Buckingham L; Mechetner EB; Roninson IB; Coon JS Oncol Res; 1998; 10(4):185-92. PubMed ID: 9778689 [TBL] [Abstract][Full Text] [Related]
13. Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx. Drew L; Groome N; Warr JR; Rumsby MG Oncol Res; 1996; 8(6):249-57. PubMed ID: 8895200 [TBL] [Abstract][Full Text] [Related]
14. Effect of protein kinase C on multidrug resistance of multidrug-resistant colorectal cancer LoVo/Adr cells. Ma Q; Zhang ZS; Zhang YL; Wang QY; Lai ZS Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):626-8. PubMed ID: 12376294 [TBL] [Abstract][Full Text] [Related]
15. In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells. Dong ZY; Ward NE; Fan D; Gupta KP; O'Brian CA Mol Pharmacol; 1991 Apr; 39(4):563-9. PubMed ID: 2017156 [TBL] [Abstract][Full Text] [Related]
16. Changes in protein kinase C subspecies protein expression and activity in a series of multidrug-resistant human KB carcinoma cell lines. Drew L; Groome N; Hallam TJ; Warr JR; Rumsby MG Oncol Res; 1994; 6(9):429-38. PubMed ID: 7703529 [TBL] [Abstract][Full Text] [Related]
17. Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines. Ford JM; Bruggemann EP; Pastan I; Gottesman MM; Hait WN Cancer Res; 1990 Mar; 50(6):1748-56. PubMed ID: 1968358 [TBL] [Abstract][Full Text] [Related]
18. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Chaudhary PM; Roninson IB Oncol Res; 1992; 4(7):281-90. PubMed ID: 1360276 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway. Jalava A; Akerman K; Heikkilä J J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723 [TBL] [Abstract][Full Text] [Related]
20. Decreased phorbol ester receptor and protein kinase C in P388 murine leukemic cells resistant to etoposide. Ido M; Sato K; Sakurai M; Inagaki M; Saitoh M; Watanabe M; Hidaka H Cancer Res; 1987 Jul; 47(13):3460-3. PubMed ID: 3581082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]